Physician profile
Catherine Pechon
NPI 1598177974
$1,858.55
in general payments reported to CMS, 2019-2025
24 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,040 · 2020: $393 · 2022: $28.93 · 2023: $150 · 2024: $119 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $294.22 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $262.44 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.57 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $123.96 | 2019-2020 | |
| Pfizer INC. | $101.69 | 2019-2025 | |
| Glaxosmithkline, LLC. | $99.34 | 2019-2023 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $98.91 | 2019-2020 | |
| Inspire Medical Systems, INC. | $98.60 | 2023 | Inspire |
| Lilly USA, LLC | $85.03 | 2019-2020 | |
| Amgen INC. | $68.68 | 2019-2020 | |
| Exact Sciences Corporation | $67.04 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $66.92 | 2019-2020 | |
| Amarin Pharma, INC. | $44.64 | 2019 | |
| Siemens Medical Solutions USA, INC. | $37.92 | 2023 | Ai-Rad Companion (Musculoskeletal) |
| Vivus LLC | $33.42 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $31.84 | 2019-2020 | |
| Dexcom, INC. | $28.93 | 2022 | |
| Allergan, INC. | $26.91 | 2019 | |
| Organon LLC | $20.71 | 2025 | Nexplanon |
| Abbott Laboratories | $20.27 | 2025 | Freestyle Libre |
| Sumitomo Pharma America, INC. | $17.12 | 2024 | Gemtesa |
| Zyla Life Sciences, INC. | $13.80 | 2019 | |
| Astellas Pharma US INC | $13.43 | 2020 | |
| Radius Health, INC. | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Pechon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.